 VANCOUVER, British Columbia and SEATTLE, Feb. 17, 2021 GLOBE NEWSWIRE -- Chinook Therapeutics, Inc. NASDAQ: KDNY, a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in a virtual fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 at 10:00 am ET. 